Use the Back button in your browser to see the other results of your search or to select another record.
| Aerobic as well as resistance exercises are good for patients with type 1 diabetes | 
| Wrobel M, Rokicka D, Czuba M, Golas A, Pyka L, Greif M, Szymborska-Kajanek A, Strojek K | 
| Diabetes Research and Clinical Practice 2018 Oct;144:93-101 | 
| clinical trial | 
| 4/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: No; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* | 
| 
                     AIMS: To assess whether aerobic or resistance training has greater benefits in non-physically active men with a long lasting type 1 diabetes. The effects of exercise were evaluated in terms of diabetes control and risk factors for cardiovascular complications. METHODS: 21 male participants (mean age 37yrs, diabetes duration 23yrs, mean HbA1c 7.4%) randomly assigned to 2 groups: (1) aerobic training (n = 10) and (2) resistance training (n = 11). All subjects participated in 60-minute training sessions, either aerobic or resistance, twice a week for three months. At baseline and after 3 months Echocardiography, ECG and incremental exercise test, ECG and blood pressure monitoring, lipid profile, lactate and diabetes control parameters were assessed in all patients. RESULTS: Baseline HbA1c was 7.44% in aerobic group and 7.36% in resistance group (p = 0.84). After 3 months there was no significant change in HbA1c value in any exercise group but a non-statistically significant downward trend was seen particularly in aerobic exercise group (p = 0.07) versus the resistance group (p = 0.15). There was no significant difference in body mass, risk of hypoglycemia and cardiovascular risk factors. CONCLUSIONS: Both forms of exercise are safe in terms of glycemic control and cardiovascular risk factors in patients with quite well-controlled type 1 diabetes without advanced late complications.  
  |